天天精品资源在线观看,亚洲精品在线影院,女性私人爽爽影院免费观看国产,亚洲中文字幕aⅴ天堂自拍

  • Neurointervention
    • 數(shù)據(jù)庫收錄SCIE
    • 年發(fā)文量29

    Neurointervention

    期刊中文名:神經(jīng)介入ISSN:2093-9043E-ISSN:2233-6273

    該雜志國際簡稱:NEUROINTERVENTION,是由出版商Korean Society of Interventional Neuroradiology出版的一本致力于發(fā)布--研究新成果的的專業(yè)學術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學術(shù)論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術(shù)發(fā)展,為廣大讀者服務。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術(shù)影響力。

    基本信息:
    期刊簡稱:NEUROINTERVENTION
    是否OA:開放
    是否預警:
    Gold OA文章占比:100.00%
    出版信息:
    出版地區(qū):Korea, Republic of
    出版語言:English/Korean
    出版商:Korean Society of Interventional Neuroradiology
    評價信息:
    JCR分區(qū):Q4
    影響因子:1.2
    CiteScore:1.8
    雜志介紹 JCR分區(qū) CiteScore 投稿經(jīng)驗

    雜志介紹

    Neurointervention雜志介紹

    《Neurointervention》是一本以English/Korean為主的開放獲取國際優(yōu)秀期刊,中文名稱神經(jīng)介入,本刊主要出版、報道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為1.2,最新CiteScore 指數(shù)為1.8。

    英文介紹

    Neurointervention雜志英文介紹

    Neurointervention is an academic journal dedicated to the field of neurointervention, aiming to provide a platform for researchers and clinical doctors in neuroscience, interventional radiology, neurosurgery, and related interdisciplinary fields to exchange the latest research results, clinical practices, and technological innovations. This magazine covers a wide range of topics in neurointerventional therapy, including but not limited to cerebrovascular diseases, intracranial tumors, spinal cord diseases, as well as diagnostic and therapeutic techniques related to neurointerventional therapy. Neurointervention is a medical branch that utilizes minimally invasive techniques for the diagnosis and treatment of brain and spinal cord diseases. It includes endovascular treatments such as embolization of cerebral aneurysms, stent implantation for cerebral vascular stenosis, and non vascular interventions such as biopsy and treatment of intracranial tumors. The development of these technologies has greatly improved the treatment effectiveness for cerebrovascular diseases and other neurological disorders, reducing surgical risks and recovery time.

    The magazine ensures the scientific and innovative nature of its published articles through a rigorous peer review process, thereby promoting the development and progress of the field of neural intervention. This journal not only focuses on basic research, but also emphasizes clinical applications, providing readers with a comprehensive perspective from laboratory research to clinical practice. In addition, the journal also pays special attention to the application and effectiveness of neurointerventional techniques in different populations, as well as how to improve the safety and effectiveness of treatment.

    JCR分區(qū)(2023-2024年最新版)

    Neurointervention雜志 JCR分區(qū)信息

    按JIF指標學科分區(qū)
    學科:CLINICAL NEUROLOGY
    收錄子集:ESCI
    分區(qū):Q4
    排名:227 / 277
    百分位:

    18.2%

    按JCI指標學科分區(qū)
    學科:CLINICAL NEUROLOGY
    收錄子集:ESCI
    分區(qū):Q4
    排名:231 / 278
    百分位:

    17.09%

    JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計信息的期刊評價資源。每年發(fā)布的JCR分區(qū),設置了254個具體學科。JCR分區(qū)根據(jù)每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。

    CiteScore 評價數(shù)據(jù)(2024年最新版)

    Neurointervention雜志CiteScore 評價數(shù)據(jù)

    • CiteScore 值:1.8
    • SJR:0.338
    • SNIP:0.6
    學科類別 分區(qū) 排名 百分位
    大類:Medicine 小類:Radiology, Nuclear Medicine and Imaging Q3 221 / 333

    33%

    大類:Medicine 小類:Neurology (clinical) Q3 281 / 400

    29%

    歷年影響因子和期刊自引率

    投稿經(jīng)驗

    Neurointervention雜志投稿經(jīng)驗

    該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認可很高,對稿件內(nèi)容的創(chuàng)新性和學術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 12 Weeks ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。

    免責聲明

    若用戶需要出版服務,請聯(lián)系出版商。